Smart Scales, Photo Logs, and Check-Ins: What Platforms Actually Require Between Refills

Some platforms refill on autopilot; others gate your next shipment behind a weigh-in. Here's the spectrum of between-refill requirements, why they exist, and what actually happens when you ignore them.

Process verified · Updated August 2026

Sign up for three different GLP-1 platforms and you'll meet three different philosophies of follow-up. One ships monthly with barely a question. One pings you a check-in form each refill. One mails you a cellular smart scale and expects weekly weights. None of this is random — between-refill requirements are how each platform satisfies its clinical, legal, and quality obligations — but patients deserve to know what's actually mandatory, what's optional engagement fluff, and what skipping costs.

The requirement spectrum

• Refill questionnaires (most common): a short form before some or all refills — current weight, side effects, adherence, any new medications or conditions. This is the platform's prescriber legally re-confirming that continuing (or escalating) remains appropriate. Usually genuinely mandatory: unanswered forms pause shipments.
• Weight check-ins / smart-scale syncing: some programs include a connected scale and want a regular weight stream. Clinically this powers real titration decisions (trend data beats a single self-reported number); operationally it's also engagement and outcomes data for the platform. Mandatory-ness varies — read whether shipments gate on it or it's merely encouraged.
• Progress photos: occasionally requested, near-universally optional. Decline freely if it's not for you; a platform that hard-requires body photos for a medication refill deserves a skeptical read of its reasoning.
• Periodic synchronous visits: some platforms require a video touchpoint at intervals or at dose milestones — the discretion layer showing up on a schedule. These are typically real requirements with real clinical purpose.
• Lab work: less common in weight-only programs, standard where metabolic monitoring applies (A1C, lipids) or when your history warrants it. When requested, it's worth doing — it's the difference between medication dispensing and actual care.

What skipping actually costs

1. First consequence: shipment holds. Gated requirements pause your refill until completed — the most common cause of "where's my order" tickets after failed payments.
2. Second: default decisions. No check-in data means your clinician decides conservatively — typically holding your dose rather than escalating. Silence reads as "no information," and no information never argues for change.
3. Third: program standing. Chronic non-response can trigger a required visit before any further refills — the platform escalating to confirm you're still an engaged, safe patient.

Matching the model to your temperament

Neither philosophy is wrong — pick the one you'll actually comply with. If structured accountability helps you, Ivim's weekly clinical check-ins make monitoring the product rather than a chore:

If you want solid support without heavy gating, Novi pairs all-in pricing with free coaching and lightweight logistics:

The bottom line

Between-refill requirements are the visible part of a platform's clinical conscience: forms that re-authorize your care, weights that power real dose decisions, and occasional visits where judgment is due. Know which items gate your shipments, do those promptly, and let the rest be exactly as optional as it claims to be.